Literature DB >> 8831330

Ketamine blocks currents through mammalian nicotinic acetylcholine receptor channels by interaction with both the open and the closed state.

M Scheller1, J Bufler, I Hertle, H J Schneck, C Franke, E Kochs.   

Abstract

Single channel recordings have shown that ketamine (Ket) decreases the open time of the nicotinic acetylcholine receptor channel (nAChR). The present experiments on simultaneous openings of the nAChRs of mouse myotubes investigate the interaction of Ket with the open as well as with the closed state of the channels. The patch-clamp technique was used to record currents activated by 10(-4) M acetylcholine (ACh) in the outside-out mode. ACh together with increasing concentrations of Ket was applied with a piezo-driven system. In a second protocol, the patches were preexposed to Ket before activation with ACh. With addition of Ket, the currents showed a biexponential decay, indicating an open-channel block. The peak current amplitude decreased reversibly and in a concentration-dependent manner. The rate constants of block (b+1) and of unblock (b-1) were modeled by computer simulation and were found to be: b+1 = 3 x 10(6) M/s, b-1 = 100/s. Preexposure of the patches to Ket revealed an additional block with a KD of approximately 2 x 10(-6) M, which is below clinical concentrations. These data suggest that Ket also interacts with the closed state of the nAChR.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8831330     DOI: 10.1097/00000539-199610000-00031

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  17 in total

Review 1.  General anaesthetic actions on ligand-gated ion channels.

Authors:  M D Krasowski; N L Harrison
Journal:  Cell Mol Life Sci       Date:  1999-08-15       Impact factor: 9.261

2.  Ketamine impairs excitability in superficial dorsal horn neurones by blocking sodium and voltage-gated potassium currents.

Authors:  Rose Schnoebel; Matthias Wolff; Saskia C Peters; Michael E Bräu; Andreas Scholz; Gunter Hempelmann; Horst Olschewski; Andrea Olschewski
Journal:  Br J Pharmacol       Date:  2005-11       Impact factor: 8.739

Review 3.  Neuronal activity: from in vitro preparation to behaving animals.

Authors:  François Windels
Journal:  Mol Neurobiol       Date:  2006-08       Impact factor: 5.590

4.  Binge and Subchronic Exposure to Ketamine Promote Memory Impairments and Damages in the Hippocampus and Peripheral Tissues in Rats: Gallic Acid Protective Effects.

Authors:  G F Brum; H Z Rosa; D R Rossato; J L O Rosa; V G Metz; L H Milanesi; M E Burger
Journal:  Neurotox Res       Date:  2020-05-26       Impact factor: 3.911

Review 5.  Reviewing the ketamine model for schizophrenia.

Authors:  Joel Frohlich; John D Van Horn
Journal:  J Psychopharmacol       Date:  2013-11-20       Impact factor: 4.153

6.  Potentiation of μ-opioid receptor-mediated signaling by ketamine.

Authors:  Achla Gupta; Lakshmi A Devi; Ivone Gomes
Journal:  J Neurochem       Date:  2011-09-20       Impact factor: 5.372

7.  Ketamine and its preservative, benzethonium chloride, both inhibit human recombinant alpha7 and alpha4beta2 neuronal nicotinic acetylcholine receptors in Xenopus oocytes.

Authors:  K M Coates; P Flood
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

8.  Nitrous oxide-induced analgesia does not influence nitrous oxide's immobilizing requirements.

Authors:  Steven L Jinks; Earl Carstens; Joseph F Antognini
Journal:  Anesth Analg       Date:  2009-10       Impact factor: 5.108

9.  Ketamine, but not phencyclidine, selectively modulates cerebellar GABA(A) receptors containing alpha6 and delta subunits.

Authors:  Wulf Hevers; Stephen H Hadley; Hartmut Lüddens; Jahanshah Amin
Journal:  J Neurosci       Date:  2008-05-14       Impact factor: 6.167

Review 10.  Ketamine and peripheral inflammation.

Authors:  Marc De Kock; Sebastien Loix; Patricia Lavand'homme
Journal:  CNS Neurosci Ther       Date:  2013-04-10       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.